Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP
| Report ID | 260260 |
| Drug Identification Number | 02220288 |
| Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Common or Proper name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | PENICILLIN G |
| Strength(s) | 5000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 5 MIU |
| ATC code | J01CE |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-06-12 |
| Estimated end date | 2025-11-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-06-13 |
| Company comments | Contract customers are allocated 50% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-06-13 | French | Compare |
| v1 | 2025-06-13 | English | Compare |
Showing 1 to 2 of 2